Areas of Focus


Expanding our research focus through a collaboration with Regeneron, we are targeting unmet needs in immune diseases including rheumatoid arthritis, atopic dermatitis, asthma, and nasal polyposis.

Immunology is an area of growth for Sanofi Genzyme and an area in which we hope to make a significant difference in patients’ lives. In collaboration with Regeneron, we are researching and developing two new therapies.

The first therapy under investigation is for the treatment of adults with moderate to severe rheumatoid arthritis, a chronic and painful inflammatory disorder that damages the joints. The second, under review with the U.S. FDA is a new therapy under investigation for adults with moderate to severe atopic dermatitis, an autoimmune disorder affecting the skin.

We are also studying other allergic and respiratory diseases, including asthma and nasal polyposis.

Our Inspiration
Last Updated: 12/7/2016
Contact Us
Genzyme Corporation

500 Kendall Street
Cambridge, MA 02142
T: 617-252-7500
F: 617-252-7600

Send Email
Atopic Dermatitis: From Education to Empowerment

Understand AD is a national awareness campaign focused on educating people about moderate-to-severe atopic dermatitis (AD), a chronic form of eczema that can be serious. By educating Americans about the physical and quality of life impact of atopic dermatitis, Understand AD will give a voice to and empower the people living with the disease.